To support this notion, PGC-1α purified from cardiomyocytes treated with α1-adrenergic agonist phenylephrine had reduced ability to bind to the Idh3a promoter, mimicking a pathological consequence of heart failure (25). This evidence concerns the gene PPARGC1A and heart failure.